Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Lipsi

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biomedicines|January 28, 2026
Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel PathwaysLorenzo Carriera, Roberto Lipsi, Meridiana Dodaj, et al.
Advances in Respiratory Medicine|March 24, 2026
Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World StudyLorenzo Carriera, Angelo Coppola, Roberto Lipsi, et al.
Current Allergy and Asthma Reports|May 16, 2026
Impact of IL-4/IL-13 Blockade with Dupilumab on the Microbiome in Type 2 Inflammatory Diseases: A Systematic ReviewPier-Valerio Mari, Lorenzo Carriera, Angela Saviano, et al.
Current Allergy and Asthma Reports|April 16, 2026
Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical EvidencePier-Valerio Mari, Lorenzo Carriera, Simone Ielo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biomedicines|January 28, 2026
Most Promising Emerging Therapies for Pulmonary Fibrosis: Targeting Novel PathwaysLorenzo Carriera, Roberto Lipsi, Meridiana Dodaj, et al.
Advances in Respiratory Medicine|March 24, 2026
Impact of Dupilumab on Small Airway Disease in Severe Asthma: A 12-Month Retrospective Real-World StudyLorenzo Carriera, Angelo Coppola, Roberto Lipsi, et al.
Current Allergy and Asthma Reports|May 16, 2026
Impact of IL-4/IL-13 Blockade with Dupilumab on the Microbiome in Type 2 Inflammatory Diseases: A Systematic ReviewPier-Valerio Mari, Lorenzo Carriera, Angela Saviano, et al.
Current Allergy and Asthma Reports|April 16, 2026
Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical EvidencePier-Valerio Mari, Lorenzo Carriera, Simone Ielo, et al.
Pageof 2